SCHEMBL20767191

SCHEMBL20767191

COc1ccc(CN(Cc2ccc(OC)cc2)C(=O)CC2CCN(C)CC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.57
MAPT P10636 1/20 0.48
CHRM5 P08912 3/20 0.47
CHRM1 P11229 2/20 0.47
CHRM3 P20309 2/20 0.47
RAB9A P51151 1/20 0.46
USP2 O75604 1/20 0.46
TSHR P16473 1/20 0.46
OPRM1 P35372 2/20 0.45
TLR7 Q9NYK1 1/20 0.45
ALDH1A1 P00352 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
MCHR1 Q99705 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20767249 0.94 HTR2A (0.52) HTR2AMAPTCHRM5CHRM1CHRM3
SCHEMBL20766869 0.84 HTR2A (0.50) HTR2ACHRM5CHRM1CHRM3OPRM1
SCHEMBL20766920 0.83 HTR2A (0.56) HTR2AMAPTCHRM1OPRM1SMN1; SMN2
SCHEMBL20767208 0.79 HTR2A (0.52) HTR2AOPRM1ALDH1A1SMN1; SMN2
SCHEMBL20767243 0.78 ALDH1A1 (0.46) HTR2AMAPTCHRM1CHRM3USP2
SCHEMBL20767250 0.77 HTR2A (0.67) HTR2A
SCHEMBL20767185 0.77 HTR2A (0.53) HTR2A
SCHEMBL20766914 0.77 HTR2A (0.54) HTR2AMAPTCHRM5CHRM1CHRM3
SCHEMBL29037239 0.76 HTR2A (0.55) HTR2ACHRM1OPRM1HRH3
SCHEMBL1646818 0.76 HTR2A (0.68) HTR2AMAPTOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019040105-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO claimed
WO-2019040105-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO disclosed
WO-2019040105-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO disclosed